Last reviewed · How we verify
NCT04670549
Improve Osteoarthritis Care
NA trial testing Implementation of treatment guidelines in Osteoarthritis, Knee in 1,541 participants. Completed in 1 July 2023.
9 February 2023
Quick facts
| Lead sponsor | Diakonhjemmet Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1,541 |
| Start date | 13 November 2020 |
| Primary completion | 9 February 2023 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Implementation of treatment guidelines
Conditions studied
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
- Osteoarthritis, Hip — all drugs for Osteoarthritis, Hip →
Sponsor
Diakonhjemmet Hospital
Who can join
Eligibility, any sex, with Osteoarthritis, Knee or Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of The Improve Osteoarthritis Care study is to improve the quality of osteoarthritis care in Norwegian primary care, by increasing the use of recommended treatment modalities and improving patient access to recommended treatments. The study will use tailored implementation strategies, targeting primary care physicians and physiotherapists to improve knowledge and addressing individual barriers to providing recommended treatments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04670549
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis, Knee
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
- NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
- NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
- NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting
Other Diakonhjemmet Hospital trials
Trials by the same sponsor.
- NCT07003932 — Remote Monitoring After Total Knee Replacement · NA · recruiting
- NCT06656845 — Feasibility of a Self-management App for People With Knee Osteoarthritis (OA-AID Feasibility Study) · NA · completed
- NCT07106931 — Early STratification of Acute ARThritis · recruiting
- NCT06440629 — Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Ar · Phase 4 · recruiting
- NCT06281184 — A 30-month Follow-up of MERINO Participants to Evaluate Long-term Effects of Methotrexate in Erosive Hand OA. · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04670549 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Diakonhjemmet Hospital
- Last refreshed: 21 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04670549.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing